Study of the Prevalence of Iron Deficiency in Patients With Chronic Inflammatory Bowel Disease
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 1,100
- 主要终点
- Ferritinemia according to inflammatory status
研究概览
简要总结
Despite its known prevalence in IBD, a recent study conducted with Prof. Cacoub (unpublished) on the national health insurance database showed that iron deficiency was an under-diagnosed and under-treated co-morbidity. In chronic diseases including IBD, Transferrin Saturation Factor is only performed in approximately 10% of cases, whereas it is recommended in inflammatory situations including IBD patients (HAS 2011).
The objective of this study is therefore to obtain updated French data on the prevalence of iron deficiency in patients with IBD by applying the recommendations of ECCO and French Health High Authority (determination of ferritinemia and Transferrin Saturation Factor)
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient, male or female, over 18 years old
- •Patient present at the hospital on the day of the study
- •Diagnosis of IBD on international criteria
- •Patient giving written consent
排除标准
- •Protected patient: major under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision;
- •pregnant, lactating or parturient woman;
- •Patient hospitalized without consent
研究组 & 干预措施
IBD
干预措施: Iron status testing (Diagnostic Test)
结局指标
主要结局
Ferritinemia according to inflammatory status
时间窗: One day
Ferritinemia will be assessed from blood sample (iron status)
次要结局
未报告次要终点